Comparison of a Personalized Maintenance Therapy With the Standard Treatment in Pemphigus

NCT05898308 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

133

Enrollment

OTHER

Sponsor class

Conditions

Pemphigus
Dermatologic Disease

Interventions

DRUG: RiTUXimab Injection

Sponsor

University Hospital, Rouen